Bird David, Beasley Matthew, Nix Michael G, Tyyger Marcus, McCallum Hazel, Teo Mark, Gilbert Alexandra, Casanova Nathalie, Cooper Rachel, Buckley David L, Sebag-Montefiore David, Speight Richard, Henry Ann M, Al-Qaisieh Bashar
Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
Radiotherapy Research Group, Leeds Institute of Medical Research, UK.
Phys Imaging Radiat Oncol. 2021 Jul 18;19:72-77. doi: 10.1016/j.phro.2021.07.005. eCollection 2021 Jul.
Magnetic resonance (MR)-only treatment pathways require either the MR-simulation or synthetic-computed tomography (sCT) as an alternative reference image for cone beam computed tomography (CBCT) patient position verification. This study assessed whether using T2 MR or sCT as CBCT reference images introduces systematic registration errors as compared to CT for anal and rectal cancers.
A total of 32 patients (18 rectum,14 anus) received pre-treatment CT- and T2 MR- simulation. Routine treatment CBCTs were acquired. sCTs were generated using a validated research model. The local clinical registration protocol, using a grey-scale registration algorithm, was performed for 216 CBCTs using CT, MR and sCT as the reference image. Linear mixed effects modelling identified systematic differences between modalities.
Systematic translation and rotation differences to CT for MR were -0.3 to + 0.3 mm and -0.1 to 0.4° for anal cancers and -0.4 to 0.0 mm and 0.0 to 0.1° for rectal cancers, and for sCT were -0.4 to + 0.8 mm, -0.1 to 0.2° for anal cancers and -0.6 to + 0.2 mm, -0.1 to + 0.1° for rectal cancers.
T2 MR or sCT can successfully be used as reference images for anal and rectal cancer CBCT position verification with systematic differences to CT <±1 mm and <±0.5°. Clinical enabling of alternative modalities as reference images by vendors is required to reduce challenges associated with their use.
仅使用磁共振(MR)的治疗路径需要MR模拟或合成计算机断层扫描(sCT)作为锥形束计算机断层扫描(CBCT)患者位置验证的替代参考图像。本研究评估了与CT相比,使用T2 MR或sCT作为CBCT参考图像用于肛管和直肠癌时是否会引入系统配准误差。
共有32例患者(18例直肠癌、14例肛管癌)接受了治疗前CT和T2 MR模拟。采集了常规治疗CBCT。使用经过验证的研究模型生成sCT。使用灰度配准算法,对216幅CBCT分别以CT、MR和sCT作为参考图像执行局部临床配准方案。线性混合效应模型确定了不同模态之间的系统差异。
对于肛管癌,与CT相比,MR的系统平移和旋转差异分别为-0.3至+0.3 mm和-0.1至0.4°,直肠癌分别为-0.4至0.0 mm和0.0至0.1°;对于sCT,肛管癌分别为-0.4至+0.8 mm、-0.1至0.2°,直肠癌分别为-0.6至+0.2 mm、-0.1至+0.1°。
T2 MR或sCT可以成功用作肛管和直肠癌CBCT位置验证的参考图像,与CT的系统差异<±1 mm和<±0.5°。供应商需要在临床上支持将替代模态用作参考图像,以减少与使用它们相关的挑战。